Cargando…
Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979447/ https://www.ncbi.nlm.nih.gov/pubmed/36864449 http://dx.doi.org/10.1186/s13046-023-02626-z |
| _version_ | 1784899727499722752 |
|---|---|
| author | Jia, Guizhi Wang, Yan Lin, Chengjie Lai, Shihui Dai, Hongliang Wang, Zhiqian Dai, Luo Su, Huizhao Song, Yanjie Zhang, Naiwen Feng, Yukuan Tang, Bo |
| author_facet | Jia, Guizhi Wang, Yan Lin, Chengjie Lai, Shihui Dai, Hongliang Wang, Zhiqian Dai, Luo Su, Huizhao Song, Yanjie Zhang, Naiwen Feng, Yukuan Tang, Bo |
| author_sort | Jia, Guizhi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9979447 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99794472023-03-03 Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 Jia, Guizhi Wang, Yan Lin, Chengjie Lai, Shihui Dai, Hongliang Wang, Zhiqian Dai, Luo Su, Huizhao Song, Yanjie Zhang, Naiwen Feng, Yukuan Tang, Bo J Exp Clin Cancer Res Retraction Note BioMed Central 2023-03-02 /pmc/articles/PMC9979447/ /pubmed/36864449 http://dx.doi.org/10.1186/s13046-023-02626-z Text en © BioMed Central 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Retraction Note Jia, Guizhi Wang, Yan Lin, Chengjie Lai, Shihui Dai, Hongliang Wang, Zhiqian Dai, Luo Su, Huizhao Song, Yanjie Zhang, Naiwen Feng, Yukuan Tang, Bo Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 |
| title | Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 |
| title_full | Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 |
| title_fullStr | Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 |
| title_full_unstemmed | Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 |
| title_short | Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 |
| title_sort | retraction note: lncarod enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform pkm2 |
| topic | Retraction Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979447/ https://www.ncbi.nlm.nih.gov/pubmed/36864449 http://dx.doi.org/10.1186/s13046-023-02626-z |
| work_keys_str_mv | AT jiaguizhi retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT wangyan retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT linchengjie retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT laishihui retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT daihongliang retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT wangzhiqian retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT dailuo retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT suhuizhao retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT songyanjie retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT zhangnaiwen retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT fengyukuan retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 AT tangbo retractionnotelncarodenhanceshepatocellularcarcinomamalignancybyactivatingglycolysisthroughinductionofpyruvatekinaseisoformpkm2 |